Title of article
Nivolumab-Induced Encephalitis in HereditaryLeiomyomatosis and Renal Cell Cancer Syndrome
Author/Authors
Chaucer, Benjamin University of Illinois College of Medicine at Peoria - Peoria - IL, USA , Stone, Abriella University of Illinois College of Medicine at Peoria - Peoria - IL, USA , Demanes, Augustus University of Illinois College of Medicine at Peoria - Peoria - IL, USA , Seibert, Shawn M. llinois Cancer Care - Peoria - IL, USA
Pages
4
From page
1
To page
4
Abstract
e treatment of cancer is a rapidly evolving field. As more chemotherapeutic agents become available, reporting the side effects ofthese agents in clinical practice becomes increasingly important. Nivolumab is one of the chemotherapeutic agents commonlyused for treatment of renal cell carcinoma, metastatic melanoma, and metastatic non-small cell lung cancer. While common sideeffects are known and well documented, encephalitis is documented as an extremely rare side effect. We present the case of anextremely rare side effect to a common chemotherapeutic agent
Keywords
Nivolumab-Induced Encephalitis , HereditaryLeiomyomatosis , Renal Cell Cancer Syndrome
Journal title
Case Reports in Oncological Medicine
Serial Year
2018
Record number
2611184
Link To Document